More HIV funding cuts coming for SA: this time a slow fade, but with clear risks
South Africa has less than eight years before one of the most important sources of funding for its HIV and TB programmes falls away. In allocation letters sent... Read more.
CAB-LA: Prevention jab that never had its moment, what it leaves behind as LEN arrives
In 2026, as South Africa prepares to introduce lenacapavir, another HIV-prevention injection is fading from view: long-acting cabotegravir, known as CAB-LA in short.... Read more.
A R60 test could help SA find millions more TB patients
A patient arrives at a clinic with a cough that has lingered for weeks. The nurse suspects tuberculosis (TB) and asks for a sputum sample—the phlegm people cough... Read more.
Here’s what’s on South Africa’s 2026 public health agenda
South Africa is a study in contrasts. And the 2026 public health agenda is no exception. Breakthrough HIV prevention medicine has arrived alongside US funding cuts.... Read more.
